Magnera misses Q3 sales and EPS; EBITDA outlook slips to low end

The quarter missed the market’s published benchmark by a wide margin. GAAP EPS was -$0.56 versus roughly $0.31 expected, while revenue was $857 million against approximately $914.4 million expected. The filing provides no company-specific consensus for adjusted EBITDA, so the cleanest scorecard is the revenue-and-EPS miss rather than the company’s favorable adjusted metric framing.

Underlying operations improved, but not enough to offset the top-line shortfall. Reported sales rose just 2%, and comparable sales were flat year over year, despite 1% organic volume growth; foreign exchange contributed $21 million while lower selling prices reduced the benefit. The better operating income and 9% adjusted EBITDA growth therefore reflect cost actions and price-cost benefits more than strong underlying revenue momentum.

The forward outlook weakened rather than merely holding steady. Management reaffirmed full-year free-cash-flow expectations but moved adjusted EBITDA expectations to the low end of the prior range, citing inflation and macroeconomic uncertainty. 〔0〕 That is a negative change in earnings power even though cash generation remains supported.

The regional mix adds risk to the miss. Americas EBITDA rose 16% on a comparable basis, but Rest of World EBITDA fell 7%; the company specifically cited inflation, delayed material pass-throughs and higher selling, general and administrative costs overseas. Netting the quarter’s better cost execution against the sizable sales and EPS gap and the lower-end EBITDA outlook, this lands as a clear earnings miss.